by Sandra Annetzberger | Jul 25, 2022 | Uncategorized
An informative open access article was published on the current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany. As one can tell from the article, the number of clincial trials for CAR-T multiple myeloma therapies is still rather low. While...
by Sandra Annetzberger | Jul 15, 2022 | Uncategorized
The 5th digital myeloma forum was a great success. On 9th July, the 5th edition of the Würzburg Myeloma Forum took place. With far more than 200 participants, mostly myeloma patients and their families as well as patient organisations, a large audience learned about...